AC Immune SA Price & Performance (ACIU)
Stock Performance
ACIU:NASDAQ
$2.23USD0.45% · $0.01
- $2.23
- $2.29
- $2.18
- $222.29M
- -3.8
- 28.97K
- $4.98
- $2.15
Open
High
Low
Market Cap
P/E Ratio
Volume
Year High
Year Low
What's Happening
Peers
Income Statement
Revenue
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Revenue | CHF 15M | CHF 0 | CHF 3.9M | CHF 15M | CHF 27M |
Cost of Revenue | CHF 59M | CHF 62M | CHF 60M | CHF 55M | CHF 0 |
Gross Profit | -CHF 44M | -CHF 62M | -CHF 56M | -CHF 40M | CHF 27M |
Gross Profit % | -286% | 0% | -1.4K% | -269% | 100% |
R&D Expenses | CHF 59M | CHF 62M | CHF 60M | CHF 55M | CHF 63M |
Cash Flow
Net Income
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Net Income | -CHF 62M | -CHF 73M | -CHF 71M | -CHF 54M | -CHF 51M |
Dep. & Amort. | CHF 2M | CHF 2.4M | CHF 2.4M | CHF 2.2M | CHF 2.2M |
Def. Tax | CHF 371K | CHF 130K | CHF 0 | CHF 0 | CHF 0 |
Stock Comp. | CHF 4.1M | CHF 4.1M | CHF 3.3M | CHF 4.4M | CHF 5.5M |
Chg. in WC | -CHF 4.6M | CHF 6.8M | -CHF 8.4M | -CHF 15M | CHF 108M |
Balance Sheet
Cash
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Cash | CHF 161M | CHF 82M | CHF 32M | CHF 78M | CHF 36M |
ST Investments | CHF 65M | CHF 116M | CHF 91M | CHF 25M | CHF 129M |
Cash & ST Inv. | CHF 226M | CHF 198M | CHF 123M | CHF 103M | CHF 165M |
Receivables | CHF 1.6M | CHF 975K | CHF 800K | CHF 15M | CHF 2.2M |
Inventory | -CHF 1.9M | -CHF 1.4M | CHF 1 | CHF 0 | CHF 0 |
Related
Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. · See all tickers.